MeritValue

Longevity Health Holdings, Inc.

XAGEdata completeness 88%5 fiscal years on file

Data notes: no data for concept 'totalDebt'

The thesis, from the filings

Longevity Health Holdings, Inc. earns about -62% on equity, and has bought back 19% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue——$01$50,3182$1.91M2
Net income−$329,3823−$9.05M4−$15.4M5−$10.4M6−$6.91M6
Operating cash flow−$451,1677−$3.43M8−$8.35M9−$3.89M10−$3.33M10
Capital expenditure—$7,16411$30,47012—$14,22513
Free cash flow (derived)—−$3.44M8−$8.38M9—−$3.34M10
Total debt—————
Cash & equivalents$774,19214$128,14915$2.91M15$157,13916$706,74016
Diluted shares—1.8M11.0M712,0911.4M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$41.04
your share of equity
Profit it earned you last year
−$48.3
Free cash flow it threw off
−$23.39
Debt you’d be carrying
—

10 shares is a claim on −$41.04 of net worth that earned you −$48.3 and generated −$23.39 of cash last year.

iii. Is this a good business?
Moat signal · return on equity
-62% avg · 5y
FY21 —FY22 —FY23 -62%FY24 —FY25 —

It earned an average -62% on equity over 5 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
−19% shares · 5y

Share count is down 19% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K/A · period ending 2023-12-31 · accession 0000950170-25-087485 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 10-K · period ending 2024-12-31 · accession 0001193125-26-134698 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 10-K · period ending 2021-12-31 · accession 0001193125-23-073837 (NetIncomeLoss)
  4. 10-K · period ending 2022-12-31 · accession 0000950170-24-038992 (NetIncomeLoss)
  5. 10-K/A · period ending 2023-12-31 · accession 0000950170-25-087485 (NetIncomeLoss)
  6. 10-K · period ending 2024-12-31 · accession 0001193125-26-134698 (NetIncomeLoss)
  7. 10-K · period ending 2021-12-31 · accession 0001193125-23-073837 (NetCashProvidedByUsedInOperatingActivities)
  8. 10-K · period ending 2022-12-31 · accession 0000950170-24-038992 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K/A · period ending 2023-12-31 · accession 0000950170-25-087485 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2024-12-31 · accession 0001193125-26-134698 (NetCashProvidedByUsedInOperatingActivities)
  11. 10-K · period ending 2022-12-31 · accession 0000950170-24-038992 (PaymentsToAcquirePropertyPlantAndEquipment)
  12. 10-K/A · period ending 2023-12-31 · accession 0000950170-25-087485 (PaymentsToAcquirePropertyPlantAndEquipment)
  13. 10-K · period ending 2025-12-31 · accession 0001193125-26-134698 (PaymentsToAcquirePropertyPlantAndEquipment)
  14. 10-K · period ending 2021-12-31 · accession 0001193125-22-106907 (CashAndCashEquivalentsAtCarryingValue)
  15. 10-K · period ending 2022-12-31 · accession 0000950170-24-038992 (CashAndCashEquivalentsAtCarryingValue)
  16. 10-K · period ending 2024-12-31 · accession 0001193125-26-134698 (CashAndCashEquivalentsAtCarryingValue)